Gerard C Grosveld

Dr. Gerard C Grosveld


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2002 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
AHAndrew D. Hollenbach
Andrew D. Hollenbach
CMCraig J. McPherson
Craig J. McPherson
EMEdwin J. Mientjes
Edwin J. Mientjes
RIRekha Iyengar
Rekha Iyengar
GGGerard C Grosveld
Gerard C Grosveld
Human Daxx is a protein that functions, in part, as a transcriptional co-repressor through its interaction with a growing number of nuclear,DNA-associated proteins. To determine the mechanism by which hDaxx represses transcription, we used conventional chromatography to isolate endogenous hDaxx. We determined that hDaxx has an apparent molecular weight of 360 kDa,which is consistent with the fact that multiple domains of hDaxx are required for transcriptional repression and suggests that hDaxx associates with multiple proteins. Using co-fractionation and co-immunoprecipitation we demonstrate that hDaxx associates with proteins that are critical for transcriptional repression, such as histone deacetylase II, constituents of chromatin such as core histones H2A, H2B, H3 and H4, and Dek, a chromatin-associated protein reported to change the topology of DNA in chromatin in vitro. We also demonstrate a requirement for the SPT domain and the first paired amphipathic helix of hDaxx for its association with histone deacetylase II and acetylated histone H4, respectively. Finally, we provide evidence suggesting that the association of hDaxx with chromatin-related proteins is dependent on the post-translational phosphorylation status of hDaxx. A working model for the repressive action of hDaxx through its association with chromatin related proteins is presented.

3 March 2003 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
PBPhilippe R.J. Bois
Philippe R.J. Bois
GGGerard C Grosveld
Gerard C Grosveld
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

9 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
IAIda Annunziata
Ida Annunziata
DVDiantha van de Vlekkert
Diantha van de Vlekkert
Elmar WolfElmar Wolf
Elmar Wolf
DFDavid Finkelstein
David Finkelstein
GNGeoffrey Neale
Geoffrey Neale
Alessandra D'azzoAlessandra D'azzo
Alessandra D'azzo
Coordinated regulation of the lysosomal and autophagic systems ensures basal catabolism and normal cell physiology, and failure of either system causes disease. Here we describe an epigenetic rheostat orchestrated by c-MYC and histone deacetylases that inhibits lysosomal and autophagic biogenesis by concomitantly repressing the expression of the transcription factors MiT/TFE and FOXH1, and that of lysosomal and autophagy genes. Inhibition of histone deacetylases abates c-MYC binding to the promoters of lysosomal and autophagy genes, granting promoter occupancy to the MiT/TFE members, TFEB and TFE3, and/or the autophagy regulator FOXH1. In pluripotent stem cells and cancer, suppression of lysosomal and autophagic function is directly downstream of c-MYC overexpression and may represent a hallmark of malignant transformation. We propose that, by determining the fate of these catabolic systems, this hierarchical switch regulates the adaptive response of cells to pathological and physiological cues that could be exploited therapeutically.

7 September 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
FHFranklin C. Harwood
Franklin C. Harwood
RGRamon Klein Geltink
Ramon Klein Geltink
BOBrendan P. O’hara
Brendan P. O’hara
MCMonica Cardone
Monica Cardone
LJLaura Janke
Laura Janke
GGGerard C Grosveld
Gerard C Grosveld
A novel mTOR complex assembled by the ETS transcription factor ETV7 contributes to rapamycin resistance in cancer.

1 March 1998 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
JBJudith Boer
Judith Boer
JBJacqueline Bonten-Surtel
Jacqueline Bonten-Surtel
GGGerard C Grosveld
Gerard C Grosveld
The human CAN gene was first identified as a target of t(6;9)(p23;q34), associated with acute myeloid leukemia and myelodysplastic syndrome, which results in the expression of aDEK-CAN fusion gene. CAN, also called NUP214, is a nuclear pore complex (NPC) protein that contains multiple FG-peptide sequence motifs. It interacts at the NPC with at least two other proteins, the nucleoporin NUP88 and hCRM1 (exportin 1), which was recently shown to function as a nuclear export receptor. Depletion of CAN in knockout mouse embryonic cells results in cell cycle arrest in G2, followed by inhibition of nuclear protein import and a block of mRNA export. We overexpressed CAN and DEK-CAN in U937 myeloid precursor cells. DEK-CAN expression did not interfere with terminal myeloid differentiation of U937 cells, whereas CAN-overexpressing cells arrested in G0, accumulated mRNA in their nuclei, and died in an apoptotic manner. Interestingly, we found that hCRM1 and import factor p97/importin β colocalized with the ectopically expressed CAN protein, resulting in depletion of both factors from the NPC. Overexpression of the C-terminal FG-repeat region of CAN, which contains the binding site for hCRM1, caused sequestering of hCRM1 in the nucleoplasm and was sufficient to inhibit cell growth and to induce apoptosis. These results confirm that CAN plays a crucial role in nucleocytoplasmic transport and imply an essential role for hCRM1 in cell growth and survival.

1 January 2012 in Skeletal Muscle
Verified
Journal Article
Open access
PDF file
AMAmy D Marshall
Amy D Marshall
GGGerard C Grosveld
Gerard C Grosveld
Rhabdomyosarcoma is a soft tissue sarcoma arising from cells of a mesenchymal or skeletal muscle lineage. Alveolar rhabdomyosarcoma (ARMS) is more aggressive than the more common embryonal (ERMS) subtype. ARMS is more prone to metastasis and carries a poorer prognosis. In contrast to ERMS, the majority of ARMS tumors carry one of several characteristic chromosomal translocations, such as t(2;13)(q35;q14), which results in the expression of a PAX3-FOXO1 fusion transcription factor. In this review we discuss the genes that cooperate with PAX3-FOXO1, as well as the target genes of the fusion transcription factor that contribute to various aspects of ARMS tumorigenesis. The characterization of these pathways will lead to a better understanding of ARMS tumorigenesis and will allow the design of novel targeted therapies that will lead to better treatment for this aggressive pediatric tumor.